CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant.
about
Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulationSynthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegansEndocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Obesity in the elderly diabetic patient: is weight loss beneficial? NoPerspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.Cannabis and psychopathology: The meandering journey of the last decadeAlterations in the hippocampal endocannabinoid system in diet-induced obese mice.Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.The future of endocannabinoid-oriented clinical research after CB1 antagonists.Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach.Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists.The multiple functions of the endocannabinoid system: a focus on the regulation of food intakeInhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids.Paradoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues.Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases.Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.Psychosocial and pharmacological interventions for the treatment of cannabis use disorder.
P2860
Q26829111-5E7E6B64-F31C-4E50-9270-C61058D03377Q28829473-41D10EAF-D61F-405E-B6B2-373A3E67A096Q30473707-495A86A3-5CCF-4552-B6AD-D84806AB780FQ33610836-B4D75B74-9D92-4146-82AF-132556A68EF9Q34495550-58FB324B-FF35-4914-8345-FD6B9D2C5E8FQ35716762-7B48B371-8E6A-45AA-ACF5-AC9C7F465739Q36795697-294CB64C-E286-4AE6-8AA0-55E2E93B2353Q36943246-ACF637AB-22D9-43D0-9276-D5C22F399797Q37226111-E10E8BC9-7249-4A72-9158-F693768E60C0Q37659341-526D7E70-C442-4548-BF5B-CAEA75A1C4CFQ37728629-4B64F3EF-1C57-4BBC-9159-39272A401D46Q37984087-F5640A26-ACC2-4B8D-93F2-3A9557E41AD7Q39419099-D41D3066-BCE3-460A-9CA6-1A938451DABDQ39455101-0D811A1B-A52D-492D-AB63-BDF61B833106Q43084633-DDDBD798-4E27-4802-A534-0D7BAC15AE8DQ45288843-D3B805CB-0077-43D4-A34D-75D7276C3DA6Q47357050-6E780EEF-88E9-437F-B25A-28D4FDFCA437Q47407342-743DC48B-3837-4C0D-97D7-03FFC9D497E2Q47797514-627A5AFC-9337-4E95-908F-BC53CC83BF9BQ48351216-F78ADFCD-9EA1-4A1A-A984-27368FBD60C2Q52316000-BA509DCF-63FA-413A-9F2B-AE9403E10010
P2860
CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CB1 receptor blockade and its ...... RIO programme with rimonabant.
@en
CB1 receptor blockade and its ...... RIO programme with rimonabant.
@nl
type
label
CB1 receptor blockade and its ...... RIO programme with rimonabant.
@en
CB1 receptor blockade and its ...... RIO programme with rimonabant.
@nl
prefLabel
CB1 receptor blockade and its ...... RIO programme with rimonabant.
@en
CB1 receptor blockade and its ...... RIO programme with rimonabant.
@nl
P2860
P1476
CB1 receptor blockade and its ...... RIO programme with rimonabant.
@en
P2093
A J Scheen
P2860
P304
P356
10.1111/J.1365-2826.2008.01681.X
P478
20 Suppl 1
P577
2008-05-01T00:00:00Z